CLINICAL_TRIALS
trial_result
· 2025-06-08
Clinical Trial Update: Ketamine for MS Fatigue [EARLY_Phase 1]
Summary
An early-phase 1 trial evaluating ketamine for fatigue in multiple sclerosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alta Bates Summit Medical Center | Conditions: Multiple Sclerosis | EARLY_Phase 1 | Status: COMPLETED